Patrick Sulem retweeted
RESEARCH ARTICLE: Resistant Hypertension Variants Link to Hyperaldosteronism and Potassium Levels @solveig @asmundurhreinn.bsky.social @fwasselbergs @TheBrunakLab @AChristensen112 @patsule
ahajrnls.org/4qSiuDQ
Bravo to the team for starting to crack the genetics of fibromyalgia. A true international effort: 2.5M multi- ancestries based on 11 groups from studies inIceland, US, Finland, Denmark, Estonia, UK . Congrats !!!
nature.com/articles/s41591-0…
3
167
In population studies, there is now multiple studies of individiuals with African ancetsry including replication / meta-analysis
Many years after starting a series of findings in Europeans, novel findings in GWAS of non-Europeans are now reported: IBKB and Lupus @NatureGenet
1
1
348
Patrick Sulem retweeted
Another incredible GWAS finding this year: an African ancestry–specific missense variant confers the largest common-variant risk effect reported to date for SLE.
Just weeks ago, there was a GWAS paper reporting the discovery of a major genetic risk factor for dilated cardiomyopathy--an African ancestry-specific loss of function variant in CD36--explaining up to 8% of the cases in African populations. (teapawt.net/doctorveera/status/198…).
Now, deCODE Genetics has uncovered a major genetic risk factor for lupus, a missense variant p.Glu502Lys in IKBKB, explaining 10.4% of cutaneous lupus (CLE) and 6.4% of cases of systemic lupus (SLE) in African populations.
The variant increases CLE risk by 5.4 fold, uncovered by comparing just 211 cases to 25,360 controls of African ancestry from the Alliance for Genomic Discovery (AGD). It highlights how deeply African ancestries have been underrepresented in lupus GWAS efforts.
Lupus is more common (2-3x) and more severe in individuals of African ancestry compared with those of European ancestry. Certain forms, like discoid lupus, are 10 times more common in African populations. Despite that, only one of the past 33 SLE GWASs involved African-ancestry population!!
Interestingly, that one study (Langefeld et al. Nat Comm 2017) that involved African ancestry individuals actually captured this IKBKB locus (connecting the signal to a different nearby gene, PLAT), but they seemed to have never identified the right gene and overlooked the importance of the finding.
Here is a plot I roughly made to highlight the effect size of this variant. The plot compares the effect sizes vs minor allele frequency of GWAS loci reported the past large SLE studies in European (Bentham et al. Nat Gen 2015) and East Asian ancestries (Yin et al. Ann Rheum Dis 2021). I overlayed the IKBKB missense variant to show the it's effect size for SLE dwarfing even the largest effect sizes reported for HLA variants.
The allele frequency of this missense variant in African ancestries is ~1%. Around 2% of the African ancestry individuals are carriers, and among the SLE/CLE cases, more than 10% carry this variant. Amazing!
Analyzing related clinical phenotypes, the authors found that the carriers tend to have a more severe phenotype (more CLE, more glomerular involvement, proteinuria and lower blood counts).
The gene IKBKB encodes an immune protein that activates the NF-κB signaling, a key immune response pathway. Partial or complete loss of IKBKB cause Mendelian forms of immunodeficiency conditions. The missense variant likely confers a gain of function effect leading to autoimmunity.
This discovery highlights the importance of NF-κB signaling in lupus pathogenesis, particularly in individuals of African ancestries. The finding has many translational implications, for example, it suggests a large target population (~10% of African cases) for any NF-κB targeted SLE treatment.
Another great work by deCODE scientists!
Thorlacius et al. Nat Gen 2025
Congratulations to my colleagues Gudny Ella and Erna.
Studying diverse ancestries as part of a large collaboration enables the discovery of association, with lupus, of an IKBKB missense quite specific to individuals with African ancestry. @NatureGenet
nature.com/articles/s41588-0…
Congratulations to my colleagues Gudny Ella and Erna.
Studying diverse ancestries as part of a large collaboration enables the discovery of association, with lupus, of an IKBKB missense quite specific to individuals with African ancestry. @NatureGenet
nature.com/articles/s41588-0…
THis is great to have the cardiomyopathy CD36 story in the same journal as our new publication. African specific genetic asociations are empowered by more diverse populations @NatureGenet
331
Sequence diversity lost in early pregnancy | Nature @nature congrats to all collaborators on this landmark paper nature.com/articles/s41586-0…
Patrick Sulem retweeted
New in Nature Metabolism: CNS GIPR and GLP-1R are both essential for weight loss response to a GIPR-Ab/GLP-1 peptide–antibody conjugate in mice—and this signaling happens through brain regions that reach outside the blood–brain barrier. This provides a new perspective on central metabolic control.
Kudos to Murielle Véniant-Ellison, @ClarissaMLiu & partners @UofT. #MyCompany
Today, @NatMetabolism published new preclinical research in mice around blocking GIPR and activating GLP-1R. 🧬🔬
This study was led by @DanielJDrucker, Endocrinologist and Professor at @UofT, and Murielle Véniant-Ellison, Scientific VP at Amgen leading #obesity research.
🔗 Learn more: amgen.ly/44e09Yz
Patrick Sulem retweeted
Delighted to see LLF580 (efimosfermin alfa) acquired by @GSK, an FGF21 biologic for MASH. Thanks to @BostonPharm for believing in this idea. Third NIBR-born spin-out to be acquired for approx $1 bn or more. endpts.com/gsk-to-pay-1-2b-u…
Patrick Sulem retweeted
At the @MilkenInstitute Global Conference panel, we discussed how AI, genetics & protein engineering are transforming drug discovery.
From our research targeting Lp(a) to uncovering potentially protective mutations in obesity, we’re entering a new era of precision and prevention.
The future of medicine is happening now. #MyCompany
Patrick Sulem retweeted
Beautiful GWAS study of body mass index (BMI) from deCODE identifying a new risk gene FRS3 associated with BMI with supporting evidence from multiple ancestries.
I particularly like the whole genome sequencing (WGS) analysis in the UK Biobank where the authors found a noncoding deletion of 262 kbp deletion downstream of MC4R reducing the BMI more than half a standard deviation--similar effect size as that of heterozygous loss of function variants in MC4R.
Deleting a regulatory region downstream of MC4R has the same effect as deleting one copy of MC4R gene. This is the kind of finding I am keenly looking for to emerge from UKB and All of Us WGS data: noncoding variants that disrupt gene function as severely as loss of function coding variants.
Note, noncoding deletion not always lead to loss of function, it can also lead to large gain of function as shown by deCODE previously for LDLR (ahajournals.org/doi/10.1161/…) where they discovered a 2.5kb deletion of 3' UTR region of LDLR in 7 individuals from a single Icelandic family, strongly reducing LDL cholesterol (related tweet: teapawt.net/doctorveera/status/173…). There the deletion removed microRNA target sites for LDLR repression, thereby increasing LDLR expression by 1.8 fold.
Jonsdottir et al. Nat Gen
nature.com/articles/s41467-0…
Happy to share this work - great collaboration with @patsule, Andrea and many others!
We report four missense variant in FRS3, each enriched in different ancestries, that associate with BMI.
nature.com/articles/s41467-0…
Fig. 2: World maps showing the allele frequency distribution of the four FRS3 missense variants identified in the study. | Nature Communications
@NatureComms obesity and genetics. Ancestry specific variants
Value of diverse ancestry nature.com/articles/s41467-0…
Patrick Sulem retweeted
Interesting rare variant study from deCODE reporting a new risk gene for bipolar disorder: HECTD2, whose gene product appears to interact with lithium target GSK3β. This is the second interactor of GSK3β to be linked to bipolar disorder (first one is AKAP11).
Thorgeirsson et al. Nat Gen
nature.com/articles/s41588-0…
Patrick Sulem retweeted
Analyses of rare genetic variants, especially in coding regions, provide unique insights into causal disease mechanisms — much more straightforward than common variant analyses🧬
In deCODE (Iceland) and UK Biobank, loss-of-function variants in HECTD2 and AKAP11 were associated with bipolar disorder🧠
Products of both genes interact with GSK3β, which is inhibited by lithium, the most potent treatment for bipolar disorder❗️
Patrick Sulem retweeted
FRS3 as a BMI-associated gene, encoding an adaptor protein known to act downstream of BDNF and TrkB, which regulate appetite, food intake, and energy expenditure through unknown signaling pathways @NatureComms nature.com/articles/s41467-0… #obesity #genetics
Patrick Sulem retweeted
Happy to share this work - great collaboration with @patsule, Andrea and many others!
We report four missense variant in FRS3, each enriched in different ancestries, that associate with BMI.
nature.com/articles/s41467-0…
Patrick Sulem retweeted
Replying to @bvhalldorsson @PalssonGunnar @decodegenetics @Skarkalinn @hakon_jon @stefansson_oa @hannespetur @patsule
Research briefing summarizing the work nature.com/articles/d41586-0…
Patrick Sulem retweeted
Replying to @bvhalldorsson @PalssonGunnar @decodegenetics @Skarkalinn @hakon_jon @stefansson_oa @hannespetur @patsule
rdcu.be/d688h - Sharing link for main paper.




















